NF-κB is activated by NOX-derived ROS in IBD [27,29,32], and the different patterns of activity shown by BJ-3105 on the one hand and D942 and tofacitinib on the other suggest BJ-3105 might regulate ROS production. Here, NFKB1 is linked to inflammatory bowel disease.